Diagnamed Holdings Corp. (CSE:DMED)
Canada flag Canada · Delayed Price · Currency is CAD
0.0650
0.00 (0.00%)
At close: Feb 9, 2026

Diagnamed Holdings Statistics

Total Valuation

CSE:DMED has a market cap or net worth of CAD 7.43 million. The enterprise value is 7.24 million.

Market Cap7.43M
Enterprise Value 7.24M

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date Jan 30, 2026
Ex-Dividend Date n/a

Share Statistics

CSE:DMED has 114.27 million shares outstanding. The number of shares has increased by 16.63% in one year.

Current Share Class 114.27M
Shares Outstanding 114.27M
Shares Change (YoY) +16.63%
Shares Change (QoQ) +8.26%
Owned by Insiders (%) 16.81%
Owned by Institutions (%) n/a
Float 94.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio -16.50
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -5.16
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.32

Current Ratio 0.32
Quick Ratio 0.30
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -421.27%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 313.05%
Weighted Average Cost of Capital (WACC) -2.08%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +200.00% in the last 52 weeks. The beta is -1.15, so CSE:DMED's price volatility has been lower than the market average.

Beta (5Y) -1.15
52-Week Price Change +200.00%
50-Day Moving Average 0.08
200-Day Moving Average 0.06
Relative Strength Index (RSI) 37.88
Average Volume (20 Days) 473,475

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.41M
Pretax Income -1.40M
Net Income -1.40M
EBITDA n/a
EBIT -1.41M
Earnings Per Share (EPS) -0.02
Full Income Statement

Balance Sheet

The company has 183,832 in cash and n/a in debt, with a net cash position of 183,832 or 0.00 per share.

Cash & Cash Equivalents 183,832
Total Debt n/a
Net Cash 183,832
Net Cash Per Share 0.00
Equity (Book Value) -450,111
Book Value Per Share -0.00
Working Capital -450,111
Full Balance Sheet

Cash Flow

Operating Cash Flow -336,069
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CSE:DMED does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -16.63%
Shareholder Yield -16.63%
Earnings Yield -18.89%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1